Zobrazeno 1 - 10
of 57
pro vyhledávání: '"Shuyue Zheng"'
Publikováno v:
Cancer Medicine, Vol 13, Iss 9, Pp n/a-n/a (2024)
Abstract Background Sentinel lymph node biopsy (SLNB) is a common choice for axillary surgery in patients with early‐stage breast cancer (BC) who have clinically negative lymph nodes. Most research indicates that obesity is a prognostic factor for
Externí odkaz:
https://doaj.org/article/565ea4076c0048a0b117321a7aaef8f9
Autor:
Weiru Chi, Bingqiu Xiu, Min Xiong, Xuliren Wang, Pei Li, Qi Zhang, Jianjing Hou, Yuting Sang, Xujie Zhou, Ming Chen, Shuyue Zheng, Liyi Zhang, Jingyan Xue, Yayun Chi, Jiong Wu
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 1, p 221 (2023)
Although targeted therapy for human epidermal growth factor receptor 2 (HER2)-positive breast cancer has significantly prolonged survival time and improved patients’ quality of life, drug resistance has gradually emerged. This study explored the me
Externí odkaz:
https://doaj.org/article/69a3eccad5fe4900872afb53fff9777e
Autor:
Shuyue Zheng, Shuang Hao, Jiajian Chen, Yingying Zhang, Benlong Yang, Xiaoyan Huang, Guangyu Liu, Zhimin Shao, Jiong Wu
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundThe latissimus dorsi flap (LDF) is the most commonly used autologous flap for breast reconstruction (BR) in China. We conducted this study to explore the current status of BR using LDF with/without implants.MethodsThis study was a single-ce
Externí odkaz:
https://doaj.org/article/a8f2501194f04c89a674e39283076a1f
Autor:
Shuyue Zheng, Lun Li, Ming Chen, Benlong Yang, Jiajian Chen, Guangyu Liu, Zhimin Shao, Jiong Wu
Publikováno v:
Breast, Vol 63, Iss , Pp 177-186 (2022)
Purpose: Neoadjuvant therapy (NAT) is considered the standard of care for patients with HER2-positive breast cancer (BC). However, there is no proven survival benefit of NAT compared to adjuvant therapy for the survival of patients with early-stage H
Externí odkaz:
https://doaj.org/article/e6607739af1242a8b56636b90b4671bc
Publikováno v:
Polymers, Vol 15, Iss 12, p 2701 (2023)
In this study, sustainable engineered cementitious composites (ECC) exhibiting high tensile strength as well as high tensile strain capacity were successfully developed by incorporating polyethylene (PE) fiber, local recycled fine aggregate (RFA), an
Externí odkaz:
https://doaj.org/article/dd41aec9c91a45f884cd6b1b88b053ad
Autor:
Hui Gan, Li Zhang, Hui Chen, Han Xiao, Lu Wang, Xuan Zhai, Ning Jiang, Ping Liang, Shuyue Zheng, Jing Zhao
Publikováno v:
Experimental and Molecular Medicine, Vol 53, Iss 11, Pp 1807-1818 (2021)
Brain hemorrhage: Reducing inflammation and brain damage Treatments that target the proteins responsible for inflammation might reduce brain damage after a hemorrhage. Sudden bleeding into the brain, known as intracerebral hemorrhage (ICH), is associ
Externí odkaz:
https://doaj.org/article/e2e9421fccc442c29e2cb7bd3e6d00d9
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Esophageal squamous cell carcinoma (ESCC) is one of the most common cancers in the world, with a high rate of morbidity. The invasion and metastasis of ESCC is the main reason for high mortality. More and more evidence suggests that metastasized canc
Externí odkaz:
https://doaj.org/article/45c11e5819f448c89334831c2872cfc9
Autor:
Dan Jian, Le Qin, Hui Gan, Shuyue Zheng, Han Xiao, Yuhao Duan, Mi Zhang, Ping Liang, Jing Zhao, Xuan Zhai
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 9, p 8320 (2023)
Intracerebral hemorrhage (ICH) is a severe cerebrovascular disease with a high disability rate and high mortality, and pyroptosis is a type of programmed cell death in the acute phase of ICH. Neuronal Per-Arnt-Sim domain protein 4 (Npas4) is a specif
Externí odkaz:
https://doaj.org/article/f9055ef276c24c5fbbde98348111a8c9
Autor:
Chongxiang Xue, Shuyue Zheng, Huijing Dong, Xingyu Lu, Xu Zhang, Jingyi Zhang, Jia Li, Huijuan Cui
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
BackgroundMounting randomized clinical trials have proved that immune checkpoint inhibitors (ICIs) achieved better overall survival (OS) and progression-free survival (PFS) than chemotherapy drugs for advanced non-small cell lung cancer (NSCLC) patie
Externí odkaz:
https://doaj.org/article/a4ef51caebbb41e6a3b4d6dc4470ade7
Autor:
Lun Li, Min Chen, Shuyue Zheng, Hanlu Li, Weiru Chi, Bingqiu Xiu, Qi Zhang, Jianjing Hou, Jia Wang, Jiong Wu
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
BackgroundTrastuzumab shows excellent benefits for HER2+ breast cancer patients, although 20% treated remain unresponsive. We conducted a retrospective cohort study to optimize neoadjuvant chemotherapy and trastuzumab treatment in HER2+ breast cancer
Externí odkaz:
https://doaj.org/article/608cda311c6b487c99f3d36123c04889